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Heart rate (HR) reduction is essential to achieve good image quality for cardiac computed tomography (CCT). We
evaluated the efficacy of a bolus injection of landiolol, an ultra-short acting β-blocker, without the administration of
oral β-blocker to reduce HR prior to CCT. We enrolled 678 consecutive patients who underwent CCT from December
2011 to March 2012 and divided them into three groups, which were a propranolol group (n = 277), a low-dose landiolol
group (n = 188), and a high-dose landiolol group (n = 213). Patients in the propranolol group received oral propranolol
(10–20 mg) prior to CCT. Patients in the low-dose and high-dose landiolol groups were administered a bolus injection of
landiolol (0.125 mg/kg), while the high-dose group received an additional 3.75 mg of landiolol if the baseline HR was
≥75/min. Although the average HR was significantly lower in the propranolol group (61.6 ± 8.0/min) than in the low-dose
landiolol group (64.1 ± 7.4/min, P < 0.001), there was no significant difference in the image quality (P = 0.91). Among
patients with baseline HR ≥75/min, the average HR tended to be lower in the high-dose landiolol group (67.2 ± 6.9/min)
compared with the low-dose landiolol group (69.0 ± 6.9/min, P = 0.10), and there was a corresponding difference in image
quality between these two groups (P = 0.02). In conclusion, Although the decrease of HR was significantly larger in the
propranolol group than in the landiolol groups, the image quality was similar. Among the patients who received landiolol,
a higher dose was associated with a lower HR and better image quality. Further investigation to assess higher-dose bolus
injection of landiolol or bolus injection following oral administration of a β-blocker would be needed.
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With the recent development of multidetector computed
tomography (MDCT), cardiac computed tomography
(CCT) has become a reliable noninvasive diagnostic
tool for coronary artery disease. (Achenbach et al. 2000;
Nieman et al. 2001; Miller et al. 2008; Budoff et al. 2008;
Meijboom et al. 2008; Raff et al. 2005). However, heart
rate (HR) reduction is essential to achieve adequate
image quality for diagnostic purposes, despite the recent
advances in CT scanner hardware that have achieved a
maximal rotation time of 270 to 350 msec. (Leschka et al.
2006; Shim et al. 2005; Muenzel et al. 2011; Korosoglou* Correspondence: kyohei@yamaji.info
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in any medium, provided the original work is pet al. 2010; Khan et al. 2011). Thus, either oral or intra-
venous β-blockers are routinely administered prior to
CCT in order to obtain adequate images. (Gerber et al.
2003; Shapiro et al. 2008; Pannu et al. 2008; Degertekin
et al. 2008; Roberts et al. 2009) Isobe et al. reported that
continuous infusion of landiolol, a highly cardioselective
and ultra-short acting β-blocker, was useful for CCT.
(Isobe et al. 2008). Recently, Osawa et al. reported that
bolus injection of landiolol following oral administration
of metoprolol achieved sufficient reduction of the heart
rate. (Osawa et al. 2013). Both of these initial studies in-
cluded a relatively small number of patients. Therefore,
we conducted a larger study to evaluate the efficacy of a
single bolus injection of landiolol without prior oral pre-
medication before CCT. The objective of the currentis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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short acting β-blocker could improve the image quality
or not.
Methods
Study population
A flow chart of the study is shown in Figure 1. A total of
1,094 consecutive patients who underwent CCT from
December 1, 2011 to March 16, 2012 at our hospital
were enrolled in this study. From December 1, 2011 to
January 22, 2012 oral propranolol (Inderal, AstraZeneca
K.K., Osaka, Japan) was administered before CCT (pro-
pranolol group), whereas intravenous landiolol hydro-
chloride (Corebeta, Ono Pharmaceutical Co., Osaka,
Japan) was injected before CCT from January 23, 2012
to March 16, 2012. The patients who received landiolol
were divided into two groups: one was given a low dose
of landiolol from January 23 to February 18 (low-dose
landiolol group) and the other was given a high dose of
landiolol from February 19 to March 16 (high-dose land-
iolol group). Exclusion criteria were as follows: CCT for
evaluation of bypass grafts or the ascending aorta, HR
before administration <60/min or >90/min, atrial fibrilla-
tion, implanted pacemaker, a history of vasospastic angina,
advanced atrioventricular block, left ventricular ejection
fraction <40%, systolic blood pressure <90 mmHg, and
known drug allergy. During the enrollment period for theFigure 1 Study flow chart. There was a low-dose landiolol group, a high-
tomography; LD, low dose; HD, high dose; HR, heart rate; BW, body weightpropranolol group, patients who had a history of bronchial
asthma were also excluded. All patients gave written in-
formed consent and this study was approved by the hospi-
tal’s institutional ethics committee.
Landiolol groups
Landiolol was injected as an intravenous bolus after ini-
tial scanning in the supine position and CCT was per-
formed from 3 to 5 minutes later. A bolus dose of
0.125 mg/kg of landiolol was administered to patients in
the low-dose landiolol group. In the high-dose landiolol
group, the same dose of landiolol was administered to
patients with a baseline HR <75/min (n = 121, 56.8%),
while both 0.125 mg/kg and an additional 3.75 mg of
landiolol were administered to patients with an HR ≥75/
min (n = 92, 43.2%). The total dose of landiolol was
limited to 12.5 mg in both groups. The low-dose and high-
dose landiolol groups were analyzed on an intention-to-
treat basis.
Propranolol group
In the propranolol group, premedication with oral pro-
pranolol (10 mg) was given at 1.5 hours before CCT for
patients with a body weight <70 kg, while 20 mg was
administered for patients with a body weight ≥70 kg.
Additional intravenous administration of β-blockers was
prohibited by the study protocol.dose landiolol group, and a propranolol group. CCT, cardiac computed
.
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Patients received premedication with nitroglycerin at
0.3 mg sublingually, unless this was contraindicated.
Scanning was performed using a 64-row MDCT scanner
(Light Speed VCT, GE Healthcare. Waukesha, Wisconsin)
with 64 × 0.625-mm collimation and a gantry rotation time
of 350 msec. The tube current was modulated with a max-
imum of 550 to 700 mA (depending on the patient’s size)
during the period between 40% and 80% of the R-R interval
and reduction by 80% during the remainder of the cardiac
cycle, while the tube voltage was fixed at 120 kV. The hel-
ical pitch was selected just before scanning from 0.16 to
0.24 depending on the heart rate: helical pitch of 0.16 for
patients with HR <36/min, 0.18 for HR <40/min, 0.20 for
HR <44/min, 0.22 for HR <48/min, 0.24 for HR <62/min,
and 0.16 for HR ≥62/min. A lower helical pitch was se-
lected in patients who were likely to have premature beats
during the main scan, whereas a higher pitch was selected
in young patients and patients who had difficulty with
breathholding. Final selection of the helical pitch was at the
discretion of the radiologist. A test bolus of iohexol (Omni-
paque 350 350 mgI/ml, Daiichi Sankyo, Tokyo, Japan) or
iopamidol (Iopamiron 370 370 mgI/ml, Bayer Yakuhin,
Osaka, Japan) was administered at a rate of 2.4 ml/sec to
5.0 ml/sec to ascertain the optimum rate and timing of in-
jection for the main scan. Then 30 ml to 80 ml of contrast
medium was injected intravenously during the main scan
and a saline bolus (20 ml) was injected intravenously imme-
diately after the contrast agent (double-bolus protocol). For
post-processing, the optimum time window was selected
for each coronary vessel from either mid-diastole (70, 75,
or 80%) of the cardiac cycle, or end-systole (40, 45, or 50%).
The “segment” and “burst” algorithms were used for
half-scan reconstruction and multisector reconstruc-
tion, respectively. The optimal reconstruction algo-
rithm was selected by viewing all images reconstructed
with both algorithms side by side. The average and
range of the HR during the main scan, total radiation
exposure, main scan duration, occurrence of prema-
ture beats, and failure to maintain breathholding dur-
ing the scan were recorded.Data analysis
Assessment of the image quality score for each coronary
vessel was done by two independent radiologists in a
blinded manner regarding the clinical background using a
previously reported five-point scale. (Leschka et al. 2006;
Shim et al. 2005). (1) no motion artifacts and clear delinea-
tion of the segment; (2) minor artifacts and mild blurring of
the segment; (3) moderate artifacts and moderate blurring
without discontinuity; (4) severe artifacts and overlap or
discontinuity of the segment; and (5) image not evaluable
and vascular structures indistinguishable (Figure 2). Theimage quality score for a patient was defined as the max-
imum image quality score among the vessels.
Statistical analysis
Categorical variables and numerical variables were
expressed as numbers and percentages. Frequency ana-
lysis was performed with the χ2 test. Variables such as the
image quality score were compared using the Kruskal-
Wallis test. Normality of distribution was tested with the
Shapiro-Wilk test. Continuous variables were expressed as
the mean ± SD and were compared by the unpaired t-test.
To compare patient characteristics among the 3 groups,
one-way analysis of variance was used. Variation in the
decrease of HR was assessed by the Bartlett’s test. All statis-
tical analyses were performed using JMP 9.03 software
(SAS Institute, Cary, NC). All reported P values are two-
sided and P < 0.05 was regarded as statistically significant.
Results
From a total of 1,094 consecutive patients who under-
went CCT, 188 patients, 213 patients, and 277 patients
were enrolled in the low-dose landiolol group, the high-
dose landiolol group, and the propranolol group, re-
spectively, while 416 patients met the exclusion criteria
and were excluded as shown in Table 1. There was no
significant difference in age, gender, height, weight, body
mass index, and HR before β-blocker administration
among the groups (Table 2).
Before β-blocker administration, the HR was >75/min
in 77 (41.0%) patients from the low-dose landiolol group
and 92 (43.2%) patients from the high-dose landiolol
group. The mean doses of landiolol in the low-dose and
high-dose landiolol groups were 7.7 ± 1.4 mg and 9.2 ±
2.2 mg, respectively. As the landiolol dose was limited
up to12.5 mg, 2 patient with low-dose group and 7 pa-
tients with high-dose group received 1.75 ± 0.18 mg and
1.36 ± 0.78 mg fewer than prespecified dose, respectively.
In the propranolol group, 10 mg of propranolol was ad-
ministered to 215 patients (77.6%) and a dose of 20 mg
was administered to 62 patients (22.4%) (Figure 1).
Low-dose landiolol versus propranolol
Although the average HR during the main scan was sig-
nificantly lower in the propranolol group (61.6 ± 8.0/
min) compared with that in the patients receiving low-
dose landiolol (64.1 ± 7.4/min, P < 0.001), the maximum
image quality score was similar between the patients
given propranolol (mean 2.43 ± 1.27) and those given
low-dose landiolol (mean 2.54 ± 1.31, P = 0.91) (Table 3
and Figure 3). Regarding CT scanning parameters, a
higher helical pitch was selected in the propranolol
group (P < 0.001). Consequently, multisector reconstruc-
tion was employed in 49.1% of the patients from the
propranolol group versus 67.7% of those receiving low-
Figure 2 Curved multiplanar reconstruction images obtained by CCT. Examples of images given each score on five-point scale.
Table 1 Exclusion criteria
Low-dose
landiolol
High-dose
landiolol
Propranolol
n = 166/
354
n = 141/
354
n = 109/386
CCT for evaluating bypass
graft or ascending aorta
51 (14.4%) 40 (11.3%) 19 (4.9%)
HR <60/min before
administration
69 (19.5%) 59 (16.7%) 37 (9.6%)
HR >90/min before
administration
16 (4.5%) 24 (6.8%) 18 (4.7%)
Atrial fibrillation 14 (4.0%) 14 (4.0%) 9 (2.3%)
Permanent pacemaker 7 (2.0%) 3 (0.8%) 3 (0.8%)
History of vasospastic angina 2 (0.6%) 0 (0.0%) 1 (0.3%)
Advanced atrioventricular
block
2 (0.6%) 1 (0.3%) 0 (0.0%)
History of asthma 0 (0.0%) 0 (0.0%) 20 (5.2%)
LVEF <40% 3 (0.8%) 0 (0.0%) 0 (0.0%)
Hypotension before
administration (systolic
BP <90 mmHg)
2 (0.6%) 0 (0.0%) 1 (0.3%)
Known drug allergy 0 (0.0%) 0 (0.0%) 1 (0.3%)
CCT, cardiac computed tomography; HR, heart rate; LVEF, left ventricular
ejection fraction; BP, blood pressure.
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the propranolol group compared with that in the pa-
tients receiving low-dose landiolol (1,343 ± 402 DLP ver-
sus 1,450 ± 335 DLP, P = 0.003). The decrease of HR was
significantly larger in the propranolol group (11.0 ± 7.2/
min) compared with that in the patients receiving low-
dose landiolol (8.8 ± 5.7/min) (P < 0.001). However, theTable 2 Patient characteristics
Low-dose
landiolol
High-dose
landiolol
Propranolol P value
(n = 188) (n = 213) (n = 277)
Age 67.6 ± 10.9 67.7 ± 11.1 67.0 ± 11.9 0.76
Male gender 104 (55.3%) 120 (56.3%) 155 (56.0%) 0.98
Height, cm 159.3 ± 8.5 159.3 ± 9.2 159.7 ± 9.2 0.90
Weight, kg 60.6 ± 11.3 60.5 ± 11.9 61.4 ± 12.9 0.67
<70 kg 149 (79.3%) 168 (78.9%) 215 (77.6%) 0.90
≥70 kg 39 (20.7%) 45 (21.1%) 62 (22.4%)
Body mass index 23.8 ± 3.3 23.7 ± 3.4 23.9 ± 3.8 0.73
HR before β-
blocker, min-1
72.9 ± 7.3 72.1 ± 7.7 72.5 ± 7.7 0.61
<75/min 111 (59.0%) 121 (56.8%) 174 (62.8%) 0.39
≥75/min 77 (41.0%) 92 (43.2%) 103 (37.2%)
HR, heart rate.
Table 3 Heart rate parameters, CCT scan parameters, and
image quality in patients receiving low-dose landiolol or
propranolol
Low-dose landiolol Propranolol P value
(n = 188) (n = 277)
HR before β-blocker,
min-1
72.9 ± 7.3 72.5 ± 7.7 0.64
Average HR during the
main scan, min-1
64.1 ± 7.4 61.6 ± 8.0 <0.001
Range of HR during the
main scan, min-1
5.9 ± 14.3 4.4 ± 10.1 0.19
Decrease of HR, min-1 8.8 ± 5.7 11.0 ± 7.2 <0.001
Time between β-blocker
administration and
main scan, min
4.0 ± 0.6 90.5 ± 16.0 <0.001
Helical pitch <0.001
Step and shoot 0 (0.0%) 5 (1.8%)
0.16 138 (73.4%) 141 (50.9%)
0.18 12 (6.4%) 26 (9.4%)
0.2 0 (0.0%) 3 (1.1%)
0.22 4 (2.1%) 22 (7.9%)
0.24 34 (18.1%) 80 (28.9%)
No. of sectors used <0.001
1 61 (32.5%) 141 (50.9%)
2 119 (63.3%) 125 (45.1%)
3 8 (4.4%) 11 (4.0%)
Total exposure, DLP 1450 ± 335 1343 ± 402 0.003
Main scan duration, sec 6.8 ± 1.1 6.4 ± 1.3 <0.001
Premature beats during
the main scan
16 (8.5%) 15 (5.4%) 0.19
Failure at breathholding 3 (1.6%) 9 (3.2%) 0.27
Presence of coronary
artery plaque
106 (56.3%) 156 (56.3%) 0.99
Presence of calcification 139 (73.9%) 199 (71.8%) 0.62
Maximum image quality
score per patient
0.91
1 55 (29.3%) 88 (31.8%)
2 42 (22.3%) 63 (22.7%)
3 44 (23.4%) 64 (23.1%)
4 29 (15.4%) 42 (15.2%)
5 18 (9.6%) 20 (7.2%)
Image quality score
per vessel
RCA 0.86
1 67 (35.6%) 106 (38.3%)
2 40 (21.3%) 66 (23.8%)
3 38 (20.2%) 50 (18.1%)
4 31 (16.5%) 40 (14.4%)
5 12 (6.4%) 15 (5.4%)
Table 3 Heart rate parameters, CCT scan parameters, and
image quality in patients receiving low-dose landiolol or
propranolol (Continued)
LAD 0.70
1 87 (46.3%) 132 (47.7%)
2 42 (22.3%) 72 (26.0%)
3 38 (20.2%) 45 (16.2%)
4 16 (8.5%) 19 (6.9%)
5 5 (2.7%) 9 (3.2%)
LCX 0.32
1 82 (43.6%) 129 (46.6%)
2 44 (23.4%) 69 (24.9%)
3 31 (16.5%) 49 (17.7%)
4 24 (12.8%) 19 (6.9%)
5 7 (3.7%) 11 (4.0%)
CCT, cardiac computed tomography; HR, heart rate; DLP, dose-length product;
RCA, right coronary artery; LAD, left anterior descending coronary artery; LCX,
left circumflex artery.
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the propranolol group, as shown in Figure 4 (32.5 versus
51.8, P < 0.001). In this study, we assessed HR variability
during the scan from the range of HR values, and found
no significant difference in the range of HR during the
main scan between patients treated with low-dose land-
iolol group and those given propranolol.
Low-dose versus high-dose landiolol
Among patients with a baseline HR ≥75/min (77 [41.0%]
patients in the low-dose landiolol group and 92 [43.2%] pa-
tients in the high-dose landiolol group), the average HR
during the main scan was tended to be lower in the high-
dose landiolol group (67.2 ± 6.9/min) compared with that
in the low-dose landiolol group (69.0 ± 6.9/min, P = 0.10),
and there was a corresponding difference of the maximum
image quality score between the high-dose landiolol group
(mean 2.53 ± 1.21) and low-dose landiolol group (mean
3.04 ± 1.41, P = 0.02) (Table 4 and Figure 3).
Possible side effects of β-blockers were reported in
two patients from the low-dose landiolol group: One pa-
tient had sinus bradycardia (40/minute) with frequent
ventricular premature beats that recovered after 5 mi-
nutes, and the other showed a decrease of blood pres-
sure from 159/95 mmHg to 86/55 mmHg that returned
to 114/78 mmHg after 10 minutes. Both patients were
asymptomatic.
Discussion
The objective of the current study was to clarify whether
the bolus injection of ultra-short acting β-blocker could
improve the image quality or not. The main findings of
this study were as follows: (1) Image quality was similar
Figure 3 Image quality scores for all patients and those with an HR ≥75/min before β-blocker administration. LD, low dose; HD,
high dose.
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http://www.springerplus.com/content/3/1/93between propranolol and low-dose landiolol, although
the decrease in HR was significantly larger in the pro-
pranolol group than in the low-dose landiolol groups. (2) In
the patients receiving landiolol with a baseline HR ≥75/
min, the higher dose was associated with a lower HR and
better image quality. (3) Variance in the decrease of HR
was significantly smaller and the mean time from adminis-
tration to performing the main scan was significantly
shorter in the landiolol groups.
Despite promising advances in MDCT, heart rate reduc-
tion is still essential for CCT. (Leschka et al. 2006; ShimFigure 4 Average heart rate before β-blocker administration and dur
landiolol group, and the propranolol group. HR indicated heart rate; LDet al. 2005; Muenzel et al. 2011; Korosoglou et al. 2010;
Khan et al. 2011). We compared a single bolus injection of
landiolol with oral administration of propranolol, and dem-
onstrated a significantly greater decrease of HR in the pro-
pranolol group without improvement of image quality. This
might be partly explained by the higher frequency of multi-
sector reconstruction with the slight increase of total ex-
posure in the landiolol groups. With a gantry rotation
speed of 350 msec, an HR of 62, 68, or 78/min becomes
the cut-off value between half-scan reconstruction and
multisector reconstruction when the helical pitch is 0.16,ing the main scan in the low-dose landiolol group, the high-dose
, low dose; HD, high dose.
Table 4 Heart rate parameters, CCT scan parameters, and
image quality in the low-dose landiolol group and the
high-dose landiolol group among patients with baseline
HR ≥75/min
Low-dose
landiolol
High-dose
landiolol
P value
(n = 77) (n = 92)
HR before β-blocker,
min-1
80.3 ± 4.3 79.7 ± 4.1 0.42
Average HR during the
main scan, min-1
69.0 ± 6.9 67.2 ± 6.9 0.10
Range of HR during the
main scan, min-1
5.3 ± 12.2 5.9 ± 14.9 0.77
Decrease at HR, min-1 11.2 ± 6.0 12.5 ± 6.1 0.18
Time between β-blocker
administration and main
scan, min
4.1 ± 0.66 3.7 ± 0.80 < 0.001
Helical pitch 0.69
Step and shoot 0 (0.0%) 0 (0.0%)
0.16 72 (93.5%) 86 (93.5%)
0.18 3 (3.9%) 5 (5.4%)
0.2 0 (0.0%) 0 (0.0%)
0.22 0 (0.0%) 0 (0.0%)
0.24 2 (2.6%) 1 (1.1%)
No. of sectors used 0.27
1 10 (13.0%) 6 (6.5%)
2 59 (76.6%) 79 (85.9%)
3 8 (10.4%) 7 (7.6%)
Total exposure, DLP 1582 ± 212 1594 ± 232 0.74
Main scan duration, sec 7.2 ± 0.63 7.5 ± 0.97 0.01
Premature beats during
the main scan
6 (7.8%) 6 (6.5%) 0.75
Failure at breathholding 1 (1.3%) 2 (2.2%) 0.67
Presence of coronary
artery plaque
32 (41.6%) 51 (55.4%) 0.07
Presence of calcification 53 (68.3%) 73 (79.4%) 0.12
Maximum image quality
score per patient
0.02
1 15 (19.5%) 21 (22.8%)
2 14 (18.2%) 28 (30.4%)
3 16 (20.8%) 23 (25.0%)
4 17 (22.1%) 13 (14.1%)
5 15 (19.5%) 7 (7.6%)
Image quality score per
vessel
RCA 0.005
1 19 (24.7%) 30 (32.6%)
2 11 (14.3%) 26 (28.3%)
3 16 (20.8%) 20 (21.7%)
Table 4 Heart rate parameters, CCT scan parameters, and
image quality in the low-dose landiolol group and the
high-dose landiolol group among patients with baseline
HR ≥75/min (Continued)
4 21 (27.3%) 10 (10.9%)
5 10 (13.0%) 6 (6.5%)
LAD 0.054
1 29 (37.7%) 39 (42.4%)
2 13 (16.9%) 32 (34.8%)
3 19 (24.7%) 11 (12.0%)
4 13 (16.9%) 8 (8.7%)
5 3 (3.9%) 2 (2.2%)
LCX 0.02
1 29 (37.7%) 44 (47.8%)
2 12 (15.6%) 20 (21.7%)
3 10 (13.0%) 17 (18.5%)
4 19 (24.7%) 8 (8.7%)
5 7 (9.1%) 3 (3.3%)
CCT, cardiac computed tomography; HR, heart rate; DLP, dose-length product;
RCA, right coronary artery; LAD, left anterior descending coronary artery; LCX,
left circumflex artery.
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and Ohnesorge 2001). The current study included patients
with an HR of around 60/min at the time of the main scan,
and there was a significant difference in the performance of
multisector reconstruction that might have improved image
quality in the patients receiving low-dose landiolol, despite
the small absolute difference of 2.5/min for the HR during
the main scan.
Leschka et al. reported that not only the absolute re-
duction of HR but also a decrease of HR variability is
important for achieving adequate image quality. (Leschka
et al. 2006). The variance in the decrease of HR was
smaller in the landiolol groups compared with the pro-
pranolol group along with the shorter time between β-
blocker administration and performance of the main
scan. We needed to avoid specific heart rates synchro-
nized with gantry rotation, as we were unable to perform
multisector reconstruction if the cardiac cycle length
was an exact multiple of the gantry rotation speed. For
example, if the patient had an HR of 86 (cardiac cycle
length = 700 msec) during the main scan, we could
not perform multisector reconstruction when the gantry
rotation speed was 350 Msec. A protocol that involves con-
tinuous infusion with stepwise dose increments might be
more beneficial for controlling the HR prior to CCT. How-
ever, the current study demonstrated that an additional
bolus dose could also reduce the HR and improve image
quality without any complications. Further investigation to
assess higher-dose bolus injection alone and bolus injection
Figure 5 Mosaic plot for maximum image quality socre and average heart rate before β-blocker in patients with low-dose
landiolol group.
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needed to clarify the efficacy of bolus landiolol compared
with a stepwise continuous infusion protocol.
In this study, two patients developed suspected side ef-
fects after bolus injection of landiolol, including transi-
ent sinus bradycardia and severe hypotension. Owing to
the short half-life of this agent, (Atarashi et al. 2000).
The adverse effects were not prolonged and resolved
completely. De Graaf et al. reported that contraindica-
tions to oral β-blocker therapy exist in a substantial pro-
portion of patients undergoing CCT, (De Graaf et al.
2010). although administration of β-blocker was essen-
tial for better image quality. Because the absolute num-
ber of patients with adverse events was small, we could not
assess the difference in the incidence of events between pa-
tients receiving bolus injection of landiolol and those given
oral propranolol. However, landiolol is a highly β1-selective
and ultra-short acting β-blocker that is expected to be asso-
ciated with less persistent adverse effects.
The present study has several limitations. First, the
dose of landiolol was specified and additional injec-
tions were prohibited by the study protocol. Adjusting
the dose of landiolol for each patient could have
achieved the optimal HR and further improved image
quality. Furthermore, a prespecified dose of 3.75 mg
and HR of 75/min would not be most effective cut off
points. However, in low-dose landiolol group, patients
with the baseline HR ≥ 75/min were prone to have poor
image quality (maximum image score ≥ 4) as compared
with those with baseline HR < 75/min as shown in
Figure 5. Second, this was not a randomized trial,
hence the results may be biased. Because the helicalpitch was set at the discretion of the radiologist, there
were substantial differences of the CT scanning param-
eters and post-processing. Although these parameters
were mainly determined automatically based on the
HR just before the main scan, the radiologists expected
that the HR would change after scanning parameters
were selected in the landiolol groups. Third, the num-
ber of patients was relatively small (especially for
evaluating safety), even though more than 400 patients
were treated with landiolol.Fourth, the low penetration
rate of step and shoot mode use could increase the ra-
diation dose. Furthermore, radiation dose did not de-
crease despite of injection of high dose landiolol. Using
step and shoot technique could be more beneficial not
only for better image quality but also for reducing radi-
ation dose. Finally, we did not evaluate the other medica-
tions prior to the CCT except for the β-blocker based on
the study protocol. Administrating the β-blocker could
not be effective in patients with prior medication of
cardiovascular drugs including β-blocker for coexisting
cardiac disease.Conclusions
Although the decrease of HR was significantly larger in
the propranolol group than in the landiolol groups, the
image quality was similar with the two β-blockers.
Among the patients receiving landiolol, a higher dose
was associated with a lower HR and better image qual-
ity. Further investigation to assess higher-dose bolus
injection of landiolol or bolus injection following oral
administration of a β-blocker would be needed.
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